Central Neurotoxicity of Immunomodulatory Drugs in Multiple Myeloma

Immunomodulatory drugs (IMiDs) currently used in the treatment of multiple myeloma, are thalidomide, lenalidomide and pomalidomide. One of the most common side effects of thalidomide is neurotoxicity, predominantly in the form of peripheral neuropathy. We report 6 cases of significant central neurot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hematol Rep
Main Authors: Patel, Urmeel H., Mir, Muhammad A., Sivik, Jeffrey K., Raheja, Divisha, Pandey, Manoj K., Talamo, Giampaolo
Formato: Artigo
Idioma:Inglês
Publicado em: PAGEPress Publications, Pavia, Italy 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378207/
https://ncbi.nlm.nih.gov/pubmed/25852850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5704
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados